Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/01/2007US20070254047 Compositions to reduce blood glucose levels and treat diabetes
11/01/2007US20070254031 Rapidly disintegrable solid preparation
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253934 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
11/01/2007US20070253904 administering a diabetic patient a formulation containing an aryl hydrocarbon receptor nuclea rtranslocator (ARNT) polypeptide to treat diabetes type I, diabetes type II, impaired glucose tolerance, insulin resistance, and beta cell dysfunction
11/01/2007CA2800389A1 Glp-1 compounds
11/01/2007CA2650124A1 Oxadiazolidinedione compound
11/01/2007CA2650027A1 Induction of weight loss and the selective inhibition of ptp1b
11/01/2007CA2649842A1 Composition containing peptide as active ingredient
11/01/2007CA2647677A1 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2629223A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/2007
10/31/2007EP1849870A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
10/31/2007EP1849795A1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
10/31/2007EP1849783A1 Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849775A1 Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849774A1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849475A1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
10/31/2007EP1848806A1 Anti-t cell and autoantigen treatment of autoimmune disease
10/31/2007EP1848749A2 Contact drug delivery system
10/31/2007EP1848721A1 Chemical compounds
10/31/2007EP1848700A1 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene]thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma
10/31/2007EP1848693A1 Indan-amide derivatives with glycogen phosphorylase inhibitory activity
10/31/2007EP1848432A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
10/31/2007EP1531807A4 Bazedoxifene treatment regimens
10/31/2007EP1425974B1 A method for processing tea flower
10/31/2007EP1392665B1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1012189B1 Treatment of obesity
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007DE60126947T2 Behandlung der glykogenspeicherkrankheit typ ii Treatment of glycogen storage disease type ii
10/31/2007DE102006019907A1 Use of substituted glycerin derivative in the preparation of a pharmaceutical composition for the prevention or treatment of e.g. cancer disease, pathological sequence of alcohol abuse, viral hepatitis and toxic nerve disorder
10/31/2007CN101065366A Dibenzyl amine compounds and derivatives
10/31/2007CN101065356A 2-arylcarboxamide-nitrogenous heterocycle compound
10/31/2007CN101065354A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/31/2007CN101065141A Plant pr-5 proteins as mammalian therapeutic agents
10/31/2007CN101065119A Ameliorant for renal insufficiency
10/31/2007CN101062947A Ciliary neurotrophy factor polypeptide allosteric and application thereof
10/31/2007CN101062919A 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
10/31/2007CN101062906A Agmatine sulfate hydrate and usage for drug rehabilitation, antiphlogistic, hypoglycemic and agmatine metabolism abnormality induced disease
10/31/2007CN101062408A Oral insulin compound medicine preparation and its preparing method
10/31/2007CN101062407A Function of erythropoietin in the preventing and treating of retinal injury
10/31/2007CN101062348A Ganoerma lucidum capusule for reducing blood sugar
10/31/2007CN101062339A Medicine for treating diabetes
10/31/2007CN101062329A Chinese traditional medicine massaging ointment for losing weight and the preparing method thereof
10/31/2007CN101062283A Tea for reducing blood sugar and its preparing method
10/31/2007CN101062282A Tea having functions of treating hyperlipidemia and high cholesterol and the preparing method thereof
10/31/2007CN101062256A Chinese traditional combination medicine for treating asthma and so on
10/31/2007CN101062248A Radix rehmanniae tuckahoe oral liquid
10/31/2007CN101062229A Nutritional medicine for promoting digestion
10/31/2007CN101062223A Chinese traditional medicine preparation for reducing blood lipid
10/31/2007CN101062207A Chinese traditional medicine for treating hyperlipomia and the preparation thereof
10/31/2007CN101062191A Decoction made from chinese wolfberry, trichosanthin and so on
10/31/2007CN101062188A Plaster for treating heat and liver disease
10/31/2007CN101062164A Method for producing sour jujube kernel acid calcium compensating agent through distilling from sour jujube kernel
10/31/2007CN101062163A Method for producing sour jujube kernel acid calcium compensating agent
10/31/2007CN101062143A Method for producing hawthorn acid calcium compensating agent
10/31/2007CN101062130A Yang recuperating decoction soft capsule preparing method
10/31/2007CN101062114A Method for distilling flavone from tartary buckwheat bran
10/31/2007CN101062086A Composite medicine for reducing blood pressure and dissolving thrombus and its preparing process
10/31/2007CN101062078A Extract of stevia whole stevioside and stevia whole flavone and the preparing method thereof
10/31/2007CN101062077A Method for preparing stevia whole stevioside and stevia whole flavone at the same time
10/31/2007CN101062071A Total saponins from radix bupleuri extract and the preparing method thereof
10/31/2007CN101062036A 5-(4-(2-n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same
10/31/2007CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin
10/31/2007CN101061862A Health-care food for diabetic patients
10/31/2007CN101061861A Health-care hypoglycermic food and its preparing method
10/31/2007CN100345866C Compound for unstable dipeptidyl peptidase IV inhibitors
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345846C Sodium sal ts of 5'-4'-2-(N-methyl-N-(2-pyridyl)amino) ethoxy [benzyl] thiazolidine-2,4-dione
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345833C Modulators of dopamine neurotransmission
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345827C Bicyclic aromatic compound
10/31/2007CN100345596C medicinal aerosol formulation
10/31/2007CN100345593C Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/31/2007CN100345589C Essential element nutritive preparation for intestine
10/31/2007CN100345577C Preparation method of high allicin garlic powder capsule
10/31/2007CN100345570C Health care product for treating intestine duct disease, preparation and use method thereof
10/31/2007CN100345566C Medicine composition used for reducing weight, prepn. method and use thereof
10/31/2007CN100345549C Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
10/31/2007CN100345545C 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect
10/31/2007CN100345540C Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/31/2007CN100345539C Composition containing dihydro myricitrin and myricitrin
10/31/2007CN100345538C Use of ampelopsin for preparing blood sugar reducing medicine
10/31/2007CN100345535C The Controlled release preparation of insulin and its method
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288528 Aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
10/30/2007US7288280 Complete feed for fish larvae and method for preparing same
10/30/2007CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/30/2007CA2183577C Methods and compositions for pulmonary delivery of insulin
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/30/2007CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/25/2007WO2007121256A2 Rapid acting and long acting insulin combination formulations
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 1298